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We previously demonstrated that trimethoprim (Tmp) resistance in Haemophilus influenzae is mediated by
chromosomally encoded dihydrofolate reductase (DHFR) with a modified primary structure and distinct
kinetic properties. To gain insight into the relationship of the DHFR structure and the level of Tmp resistance
that it confers on the host bacterium, we cloned and characterized the folH genes of one Tmp-susceptible and
two Tmp-resistant H. influenzae strains. Differences were observed between Tmp-susceptible and Tmp-resistant
isolates both in the promoter region and in the coding sequences. The effect of differences between H. influenzae
folH genes on Tmp susceptibility was investigated in Escherichia coli. Various folH gene hybrids were con-
structed, and their influence on Tmp susceptibility was determined. Resistance in E. colimediated by folH from
H. influenzae strain R1047 was associated with alterations in the promoter and the central part of folH. In
contrast, the E. coli Tmp resistance phenotype associated with the folH gene of H. influenzae R1042 was
characterized by alterations in one or more of three amino acid residues at the C-terminal part of the protein.
These data indicate that Tmp resistance is not only related to alterations in the promoter region of the folH
gene and the Tmp binding domains at the N-terminal and central part of DHFR. Alterations in the C-terminal
part may also cause Tmp resistance, probably as a result of a change in secondary structure and the
subsequent loss of Tmp binding affinity.
Trimethoprim (Tmp), 2,4-diamino-5-(39,49,59-trimethoxy-
benzyl)pyrimidine, is a synthetic compound with antibacterial
and antiparasitic activities. This drug interferes with folate
metabolism by inhibiting the activity of dihydrofolate reduc-
tase (DHFR) (8, 22). Tmp is often used in combination with
sulfamethoxazole to treat a wide variety of aerobic gram-pos-
itive and gram-negative infections (11). Tmp-resistant micro-
organisms were reported shortly after the introduction of Tmp
in the 1960s. Several mechanisms for Tmp resistance have
been described (for a review, see reference 9). The major cause
of Tmp resistance is the production of an altered (plasmid-
encoded) DHFR that lacks the capacity to bind Tmp (1, 4,
23–25). Overproduction of the normal (chromosomally en-
coded) DHFR is an additional mechanism of resistance (3, 7,
14, 23).
We previously demonstrated that Tmp resistance in Hae-
mophilus influenzae is due to chromosomally mediated over-
production of the modified DHFR (5). However, the possibil-
ity of alterations in permeability barriers or efflux pumps could
not be excluded. Subsequent purification of DHFR from Tmp-
susceptible and Tmp-resistant H. influenzae isolates indicated
that the mechanism of resistance was due to a Tmp-resistant
DHFR with modified structural and kinetic properties (6).
In the study described in this report we investigated the
effects of differences between H. influenzae folH genes on Tmp
susceptibility in Escherichia coli. The folH genes of three H.
influenzae strains displaying different levels of susceptibility to
Tmp were cloned and characterized by DNA sequencing. We
also analyzed the promoter region and the N-terminal part of
the DHFRs from nine other genetically distinct H. influenzae
isolates which varied in their Tmp susceptibilities. The effects
of the various alterations in the folH gene on the Tmp suscep-
tibility of the host were investigated in E. coli by mutagenesis
experiments with H. influenzae folH gene hybrids.
MATERIALS AND METHODS
Bacterial strains and culture conditions. The H. influenzae isolates used in the
study are listed in Table 1. These strains were grown on Haemophilus test
medium (HTM) agar plates (Oxoid) supplemented with HTM supplement
SR158 (Oxoid) and thymidine phosphorylase (Sigma, Bornem, Belgium). E. coli
DH5a (18), HB101 (18), and M1183 were also used in the study. Strain M1183
[malT lda (Pr;CI857) malPQ endA thi hsdR] was kindly provided by L. M.
Schouls, National Institute of Public Health and Environmental Protection,
Bilthoven, The Netherlands. The E. coli strains were grown aerobically at 378C
in Luria-Bertani (LB) broth and LB agar (Difco Laboratories, Detroit, Mich.)
unless stated otherwise.
Antibiotic susceptibility testing. The MIC of Tmp was determined by the agar
dilution method as described previously (11a). The E. coli recombinants con-
taining H. influenzae folH genes and gene hybrids (see below) were grown
overnight at 378C in LB broth containing 100 mg of ampicillin (Sigma) per ml
(18). The recombinants (105 CFU in 10 ml) were spotted onto Iso-Sensitest agar
plates (Oxoid, Unipath Ltd., Basingstoke, United Kingdom) containing Tmp at
graded concentrations of 0.12 to 512 mg/ml (Sigma). The MIC was defined as the
lowest concentration which completely inhibited visible growth in comparison
with that on a Tmp-free agar plate. Susceptibility testing of all strains and
recombinants was performed fourfold.
Cloning of the folH genes from various H. influenzae strains. The folH gene-
containing DNA of H. influenzae R1047 present in recombinant pRGS7 (5, 6)
was used to generate subclones in the M13 plasmids pTZ18 and pTZ19 (Sigma).
Recombinant clone pRGS12 contained a 1.5-kb EcoRI-XbaI DNA insert. The
DNA insert contained the entire folH gene because Tmp resistance was con-
ferred to E. coli HB101 by this recombinant plasmid.
The folH genes from another nine Tmp-susceptible and -resistantH. influenzae
strains from Spain were cloned. Chromosomal H. influenzae DNA was purified
(18), and the folH genes were amplified by PCR. Two oligonucleotide primers
(Applied Biosystems, Gouda, The Netherlands) were used for DNA amplifica-
tion by PCR: 59-GACGGATCCCAAGCCTGAATTAATTGGCTC (oligo-1;
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corresponding to a region upstream of the putative DHFR promoter with a
BamHI restriction site introduced at bases 4 to 9) and 59-CTAGAATTCAGTT
GCAGTTTTGCGTCATAAT (oligo-2; complementary to a region 39 to the
termination codon with an EcoRI restriction site introduced at bases 4 to 9). The
reaction mixtures contained 50 ng of chromosomal DNA, 50 pmol of each
oligonucleotide, and 1 U of Taq DNA polymerase in 100 ml of PCR buffer
(Perkin-Elmer Cetus, Gouda, The Netherlands). PCR amplification was per-
formed as described previously (17). Forty cycles of PCR (2 min at 958C, 2 min
at 568C, and 2 min at 728C) were performed, and polymerization was continued
for a further 7 min at 728C at the end of the last cycle. PCR products were
analyzed by agarose gel electrophoresis. The amplified DNA was digested with
XbaI and EcoRI, cloned into pTZ18 and pTZ19, and transformed into E. coli
HB101. The DNA cloning procedures were performed as described by Sambrook
et al. (18).
DNA sequencing. Nucleotide sequence analysis of the folH genes of the H.
influenzae strains was performed by the dideoxy nucleotide chain termination
method (19). T7 DNA polymerase (Promega, Leiden, The Netherlands) was
used in combination with the Sequenase kit of U.S. Biochemicals (Cleveland,
Ohio). DNA sequencing with double-stranded plasmid templates was performed
as recommended by the manufacturer. Taq DNA polymerase (Promega) was
used to overcome band compressions. Universal M13 primers (17-mer) were
used to initiate the sequence analysis. On the basis of the DNA sequence
information, internal primers (20-mer) were synthesized (Applied Biosystems) to
proceed with sequencing. Comparisons of different nucleotide and amino acid
sequences were performed with the FastA program (13).
DHFR domain exchange experiments. The EcoRI-XbaI restriction fragments
containing the folH genes of H. influenzae R1047 (folH1), R906 (folH2), and
R1042 (folH3) were cloned into the M13 plasmid pTZ18 and plasmid pPLc245,
containing the heat-inducible pL promoter (15). The pTZ18 and the pPLc245
recombinant were transformed into E. coli DH5a and M1183. Induction of the
pL promoter was performed at 428C (18). The restriction sites EcoRI, StyI,MunI,
and XbaI were used to construct gene hybrids by exchanging EcoRI-StyI, StyI-
MunI, or MunI-XbaI folH gene-containing fragments. DNA cloning was carried
out as described by Sambrook et al. (18). The gene hybrids were checked by
restriction fragment length polymorphism analysis. For this purpose, the restric-
tion enzymes AluI, VspI, and MboI were used.
Genetic typing of the H. influenzae strains. To verify that the Tmp-resistant H.
influenzae strains isolated in different geographic areas of Spain were not clonal,
we characterized the strains by pulsed-field gel electrophoresis as described
previously (12).
Nucleotide sequence accession numbers. The nucleotide sequences of the
DHFR genes and the flanking regions of strains R1047 (folH1), R906 (folH2),
and R1042 (folH3) are present in the EMBL, GenBank, and DDBJ databases
under the accession numbers X84205, X84206, and X84207, respectively.
RESULTS
Genetic characterization of the folH genes fromH. influenzae
R1047, R1042, and R906. The 1.5-kb EcoRI-XbaI insert
present in recombinant plasmid pRGS12 was sequenced. The
first 383 nucleotides 59 of the EcoRI site were identical to the
pGEM3 sequence. The remaining 1,144-bp sequence con-
tained an open reading frame (Fig. 1). Within this open read-
ing frame, a protein-coding sequence started at nucleotide 634
and ended at nucleotide 1113. We designated this gene folH1,
encoding the DHFR of H. influenzae R1047, for which the
Tmp MIC is 32 mg/ml. The start codon is preceded by a po-
tential ribosomal binding site (AGGG) similar to that of E. coli
and by motifs with a high degree of homology to the canonical
E. coli 210 (TATAAT) and 235 (TTGACA) promoters (Fig.
1) (20).
The PCR-amplified folH genes and flanking DNA sequences
of H. influenzae R906 and R1042 were also analyzed by DNA
sequencing. Computer analysis of the sequence revealed a
DHFR-coding sequence of 480 bp. We designated the gene of
Tmp-susceptible strain R906 folH2, while we identified that of
the high-level Tmp-resistant strain R1042 (MIC, 128 mg/ml)
folH3. Comparison of the folH genes of H. influenzae R1047,
R906, and R1042 indicated that they had approximately 95%
homology at the nucleotide level. The GC contents were 37.0%
for folH1 (strain R1047), 36.8% for folH2 (strain R906), and
37.0% for folH3 (strain R1042). The GC content of each of the
three folH genes and flanking sequences was approximately
35%. The derived amino acid sequences of the folH genes were
.91% identical.
Genetic relatedness of the Spanish H. influenzae isolates.
Before examining parts of the folH nucleotide sequences of the
Tmp-resistant Spanish isolates, we investigated the genetic het-
erogeneity of the strains. Only two of the strains, strains 1201
and 1289, had an identical pulsed-field pattern after digestion
with SmaI (Fig. 2). Both of these strains were type b. The
pattern seen with strain 1217 was nearly identical to that ob-
served with the type b strains, except that the lowest-molecu-
lar-weight band was a doublet. The overall high degree of
FIG. 1. Nucleotide sequence of the folH gene of H. influenzae R1047. The
amino acid sequence of DHFR is depicted. The 235 and 210 promoter regions
are underlined.
TABLE 1. Description of H. influenzae isolates
Strain Type Geographicorigin Isolation site
Year of
isolation
Tmp MIC
(mg/ml)
R906a ntb NAc Laboratory isolate 0.5
R1042a nt England Sputum 1981 128
R1047a nt England Eye 1981 32
1201a b Spain Blood 1987 32
1209a nt Spain Pleural fluid 1988 64
1217a nt Spain Blood 1988 0.25
1226 nt Spain Ear 1988 32
1270 nt Spain Ear 1989 16
1276a nt Spain Ear 1989 16
1288a nt Spain Conjuctiva 1989 64
1289a b Spain Pleural fluid 1989 32
1297a nt Spain Sputum 1989 0.12
1303a f Spain Cerebrospinal fluid 1989 16
1307a f Spain Nasopharynx 1989 8
a folH genes were cloned and (partial) sequence analysis was performed.
b nt, nontypeable.
c NA, not applicable.
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DNA polymorphism among the Spanish isolates indicates that
these isolates are genetically heterogeneous strains and there-
fore are epidemiologically nonrelated.
Characterization of the folH gene sequences from various
Spanish H. influenzae isolates. Since the first 70 amino acids of
DHFR are thought to be involved in Tmp binding (16), we
analyzed the folH genes of nine additional H. influenzae strains
that vary in their levels of Tmp susceptibility. The Tmp MICs
for these strains ranged from 0.12 to 64 mg/ml. The deduced
DHFR amino acid sequences did not display a consistent sub-
stitution in regions that are thought to be involved in Tmp
binding (Fig. 3). An N3 S substitution at position 13 was the
only consistent substitution in the DHFR of Tmp-resistant H.
influenzae strains in comparison with the amino acid sequences
of the Tmp-susceptible strains. In general, as the Tmp suscep-
tibility of the strain decreased, the total number of amino acid
differences in comparison with the amino acid sequences of
Tmp-susceptible strains increased.
Since overproduction of the wild-type DHFR is a mecha-
nism of Tmp resistance in E. coli, which is associated with
mutations in the promoter region (3, 7, 23), we determined the
nucleotide sequence upstream of the putative folH start codon
(Fig. 4). This region in strain R1042, which appeared to over-
produce a modified DHFR sixfold compared with the level of
production by strain R906 (6), was identical to those in the
three Tmp-susceptible strains (strains R906, 1217, and 1297)
and to those in two Tmp-resistant strains (strains 1288 and
1289) (Fig. 4). These data indicate that overproduction of
DHFR in H. influenzae R1042 compared with the level of
production in strain R906 cannot be explained by differences in
the promoter region.
DHFR production by H. influenzae R1047 was demon-
strated to be 11.5 times greater than that by R906 (6). The
DNA sequence containing the promoter region demonstrated
two nucleotide differences compared with the nucleotide se-
quence of strain R906. Furthermore, the sequence was iden-
tical to those of four Spanish isolates that were invariably
resistant to Tmp. These data suggest that the promoter se-
quence of R1047 may be responsible for DHFR overproduc-
tion and the subsequent Tmp resistance phenotype of the
strain.
FIG. 2. Pulsed-field gel electrophoresis of SmaI-digested DNA from H. in-
fluenzae strains isolated in Spain. The characteristics of the strains are summa-
rized in Table 1. Lanes: 1, 1201; 2, 1289; 3, 1307; 4, 1303; 5, 1288; 6, 1209; 7, 1217;
8, 1226; 9, 1270; 10, 1276; 11, 1297; M, molecular size markers consisting of
bacteriophage l concatemers.
FIG. 3. Comparison of the N-terminal 90 amino acids of the deduced DHFRs of H. influenzae strains with various Tmp susceptibilities. The entire DHFR sequences
of strains R1047 (folH1), R906 (folH2), and R1042 (folH3) are depicted. The Tmp MICs are also depicted.
FIG. 4. Nucleotide sequence of the promoter region of folH genes of Tmp-
susceptible and -resistant H. influenzae strains. The Tmp MICs are depicted.
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Identification of the folH gene differences responsible for
Tmp resistance in H. influenzae. The effects of the various folH
gene alterations on the Tmp susceptibility or resistance phe-
notype were investigated. The MICs for three E. coli recom-
binants containing the folH genes of H. influenzae R1047
(folH1), R906 (folH2), and R1042 (folH3), respectively, were
determined. The presence of the folH genes in E. coli invari-
ably gave an increase in resistance to Tmp in comparison with
the resistance of the wild-type strain (Fig. 5A). Furthermore,
the measured MICs for the E. coli recombinants were signifi-
cantly higher than those for the corresponding H. influenzae
strains. This may be explained by the presence of the folH
genes on a multicopy plasmid, causing an increase in the level
of expression in E. coli. The association between the level of
DHFR expression and the level of Tmp resistance demon-
strated previously (3, 5, 7, 14, 23) was confirmed, because the
presence of the heat-inducible pL promoter influenced the
level of Tmp resistance. An increase in the level of folH2 and
folH3 gene expression by heat induction of pL resulted in a
twofold increase in the level of Tmp resistance of the recom-
binants. Additionally, the pL promoter did not affect the level
of expression of the folH1 gene, presumably because of the
greater distance between pL and the structural gene (633 bp) in
comparison with the distance in the homologs folH2 and folH3
(171 bp). Alterations in the structural folH genes included
differences in 5 amino acid residues between strains R906 and
R1047 and differences in 10 amino acid residues between
strains R906 and R1042 (Fig. 6). Comparison of the three
DHFR proteins demonstrated only two conserved amino acid
substitutions, present in folH2 and folH3 at positions 74 (I7V)
and 79 (F7L), respectively, whereas all other substitutions
resulted in a change in the net protein charge (Fig. 6). In order
to investigate the influence of the various alterations in the
structural folH gene and its promoter sequence, we con-
structed various folH hybrid genes in E. coli and determined
the MICs. The restriction enzymes EcoRI, XbaI, StyI, and
MunI were applied to exchange StyI-XbaI, StyI-MunI, and
MunI-XbaI fragments between the different folH genes (Fig.
6). The gene hybrids were verified by restriction fragment
length polymorphism analysis. For this purpose, the restriction
enzymes AluI, VspI, and MboI were used. AluI was able to
discriminate the internal StyI-MunI fragments, and VspI and
MboI sites were exclusively present in the MunI-XbaI frag-
ments of folH2 and folH3, respectively. Exchange of the StyI-
XbaI fragments clearly affected the level of Tmp resistance of
folH2 and folH3 (Fig. 5B). Since Tmp resistance was entirely
transferred after StyI-XbaI exchange, we conclude that at least
one determinant(s) involved in this type of Tmp resistance is
located downstream of the StyI restriction site of folH3.
To identify the domain(s) responsible for the Tmp resistance
of folH3 strains, the StyI-MunI and MunI-XbaI fragments of
folH2 and folH3 were exchanged. The results are presented in
Fig. 5C and D. Only the alterations present in the C-terminal
part of folH3 DHFR were involved in the resistance pheno-
type, indicating that the three amino acid substitutions at po-
sitions 135 (E7K), 142 (R7H), and 154 (F7V) in the DHFR
of H. influenzae R1042 are responsible for Tmp resistance.
The Tmp resistance phenotypes of the folH1-containing
strains were also investigated by domain substitution experi-
ments. Transfer of the StyI-MunI fragments of folH1 to folH2
resulted in an increase in Tmp resistance (MIC, 8 to 128
mg/ml), whereas the folH1 recombinant containing the StyI-
MunI domain of folH2 showed a decrease in resistance (MIC,
512 to 64 mg/ml) (Fig. 5C). Since the alterations present in
folH1 strains, which led to three amino acid substitutions at
positions 54 (P7A), 56 (A7P), and 95 (I7L), are all located
at the StyI-MunI part of the gene, we conclude that the central
domain of DHFR encoded by folH1 is responsible for Tmp
resistance. In addition, exchange of the StyI-MunI fragments
between folH1 and folH3 strains also demonstrated the pres-
ence of Tmp resistance determinants in the central domain of
folH1. Transfer of the StyI-MunI fragments of folH1 to folH3
strains resulted in a twofold increase in Tmp resistance (MIC,
256 to 512 mg/ml), whereas the folH1 recombinant containing
FIG. 5. Tmp MICs of H. influenzae R906, R1047, and R1042 and the various
E. coli recombinants containing recombinant folH genes and hybrids constructed
by DHFR domain exchange mutagenesis. All recombinant plasmids were con-
structed in pTZ18. The folH1, folH2, and folH3 gene(s) and gene parts are
depicted by shaded, open, and black bars, respectively. The restriction sites
EcoRI (E), StyI (S), MunI (M), and XbaI (X) are depicted. Numbers in paren-
theses are the Tmp MICs (in micrograms per milliliter) for the H. influenzae
strains. MIC determinations were done fourfold. The MICs were repeatedly
similar. The MICs for the E. coli parent strains DH5a and M1183 were ,0.5
mg/ml.
2134 DE GROOT ET AL. ANTIMICROB. AGENTS CHEMOTHER.
the StyI-MunI domain of folH2 showed a decrease in resistance
(MIC, 512 to 64 mg/ml) (Fig. 5C). Thus, exchange of the
central domain of folH1 and folH3 clearly indicated the impor-
tance of this domain in the Tmp resistance of the folH1 re-
combinant.
To investigate the involvement of the R1047 promoter in
Tmp resistance, the EcoRI-StyI fragments of the folH genes,
containing the promoter region and the 59 part of the gene,
were exchanged (Fig. 5B). Substitution of the EcoRI-StyI frag-
ment of folH1 to folH2 resulted in an increase in Tmp resis-
tance (MIC, 8 to 64 mg/ml). On the other hand, substitution of
the EcoRI-StyI fragment of folH1 by folH2 resulted in a de-
crease in Tmp resistance (MIC, 512 to 128 mg/ml). Since two
amino acid substitutions are present at positions 13 (N7S) and
21 (M7I), we conclude that the promoter or the substitutions
at positions 13 and 21, or both the promoter and the substitu-
tions are involved in the Tmp resistance of the folH1 recom-
binant.
DISCUSSION
In the present study, the folH genes and flanking sequences
of three H. influenzae strains that vary in their levels of Tmp
resistance were characterized. The base compositions of the
folH2 gene of the Tmp-susceptible strain R906 and the folH1
and folH3 genes of Tmp-resistant strains R1047 and R1042,
respectively, were similar to that of the H. influenzae chromo-
some: G1C contents of 37.0% (folH1), 36.8% (folH2), and
37.0% (folH3), in comparison with 39% for the entire chro-
mosome (10). This observation suggests that Tmp resistance in
H. influenzae is due to alterations that occur in the species-
specific folH genes rather than the horizontal transfer of resis-
tance genes from other bacterial species.
Comparison of the translated products of the three folH
genes revealed more than 95% sequence identity. Computer
analysis of the deduced DHFR amino acid sequences demon-
strated significant homology with other prokaryotic and eu-
karyotic DHFRs. The DHFR protein of H. influenzae R1047
encoded by folH1 had 48% identity and 51.3% similarity in an
overlap of 158 amino acids with the DHFR of E. coli K-12 (21).
The homologies of the deduced protein with other prokaryotic
Tmp-resistant and -susceptible DHFRs varied between 34.9
and 49.1%. Homology with eukaryotic DHFRs was signifi-
cantly less and was mainly restricted to the first 68 amino acids.
Since overproduction of the wild-type DHFR is a mecha-
nism of Tmp resistance in E. coli, which is associated with
mutations in the promoter region, the 52-bp nucleotide se-
quence upstream of the putative folH start codon was deter-
mined in various H. influenzae strains. Since this region in the
Tmp-resistant strain R1042, which appeared to overproduce a
modified DHFR by sixfold compared with the level of produc-
tion by Tmp-susceptible strain R906 (6), was identical to the
folH promoter region of strain R906, we conclude that over-
production of DHFR is presumably caused by unknown regu-
latory mechanisms affecting the expression of DHFR.
The DHFR production of H. influenzae R1047 was demon-
strated to be 11.5 times greater than that of strain R906 (6).
We observed two nucleotide differences among the folH pro-
moter regions of these strains. Furthermore, the R1047 folH
promoter sequence was identical to the homologous sequences
in four Spanish isolates that were invariably resistant to Tmp.
These data suggest that the promoter sequence of R1047 may
be (partly) responsible for DHFR overproduction and the sub-
sequent Tmp resistance phenotype of the strain.
The effects of the various H. influenzae folH gene alterations
on the Tmp susceptibility or resistance phenotype were inves-
tigated in E. coli. Various folH gene hybrids were constructed,
and the influence on Tmp susceptibility was determined. We
demonstrated that one or more of three amino acid substitu-
tions in the C-terminal part of folH3 (strain R1042; MIC, 128
mg/ml) were associated with the expression of Tmp resistance
in E. coli. The Tmp resistance of folH1 (strain R1047; MIC, 32
mg/ml) was associated with amino acid substitutions in the
central part of DHFR. In addition, promoter activity or amino
acid substitutions in the N-terminal part of folH1, or both, were
also involved in Tmp resistance. Interestingly, the binding do-
mains of inhibitory components such as Tmp are present at the
N-terminal and central parts of the protein (2). The C-terminal
part of DHFR has never been shown to harbor binding do-
FIG. 6. Physical map of the EcoRI (E)-XbaI (X) restriction fragments containing the folH genes of H. influenzae R906, R1047, and R1042. The amino acid
differences and their positions are depicted. The black bar in the promoter region of folH1 represents 14-bp differences in comparison with the homologous DNAs in
folH2 and folH3. p, EcoRI restriction site present in the plasmid vector pTZ18.
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mains. A possible explanation for the importance of alterations
in the C-terminal part of DHFR may be the contributional
effects of this region on the maintenance of the secondary
structure of the enzyme. Alterations in this region may lead to
a change in structure, which causes a loss of or a decrease in
the level of Tmp binding and subsequently results in a Tmp
resistance phenotype.
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